Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829670 · ClinicalTrials.gov registry record
The Impact of Cytochrome P450 Abnormalities in Patients With Delirium.
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 13
- Enrollment target
NCT03829670: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03829670 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03829670 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Objectives: 1. To examine whether patients with delirium have higher prevalence of cytochrome-P450 abnormalities compared to patients without delirium. 2. To examine whether the severity of delirium is related to a specific cytochrome P450 genotype. 3. To examine the persistence of delirium at 6-8 weeks stratified by presence of cytochrome p450 abnormalities 4. To examine whether delirium persistence is impacted by types of medications administered during their hospital stay.
Primary Outcome
Statistical Analysis Plan: Descriptive statistics will be presented as mean ± SD for continuous variables and percentage/count for dichotomous/categorical variables. Chi-square test and t-test will be used to compare distribution of variables of interest between the two groups. Logistic regression analysis will be performed to estimate the risk of PEP while adjusting for all potential confounding factors.
Interventions
- DIAGNOSTIC_TEST Cytochrome P450 test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-01-31 |
| Est. Completion | 2020-06-24 |
What the finished NCT03829670 record still lists
NCT03829670 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cytochrome P450 test is the first listed.
NCT03829670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03829670 about?
NCT03829670 is a clinical study titled "The Impact of Cytochrome P450 Abnormalities in Patients With Delirium.". Objectives: 1. To examine whether patients with delirium have higher prevalence of cytochrome-P450 abnormalities compared to patients without delirium. 2. To examine whether the severity of delirium is related to a specific cytochrome P450 genotype. 3. To examine the persistence of delirium at 6-8 ...
What is the current status of trial NCT03829670?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2019-01-31. Estimated completion is 2020-06-24.
What interventions are being tested in trial NCT03829670?
The interventions under investigation include: Cytochrome P450 test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03829670?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI